Home Biosimilar Antibodies Protein Tyrosine Kinase PDGFR antibody Olaratumab (Anti-PDGFRA / CD140a) For research use only.
Not for use in humans.

Olaratumab (Anti-PDGFRA / CD140a)

Synonyms: IMC-3G3, LY3012207

Olaratumab (IMC-3G3; LY3012207) is a fully human IgG1 monoclonal antibody directed against the platelet-derived growth factor receptor alpha (PDGFR alpha) with potential antineoplastic activity. MW: 145.5 kD.

Olaratumab (Anti-PDGFRA / CD140a)

Purity & Quality Control

Batch: A237901 Purity: 99% Protein concentration: 6.3mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective PDGFR Inhibitors

Biological Activity

Description Olaratumab (IMC-3G3; LY3012207) is a fully human IgG1 monoclonal antibody directed against the platelet-derived growth factor receptor alpha (PDGFR alpha) with potential antineoplastic activity. MW: 145.5 kD.

Product Details

CAS No. 1024603-93-7
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Olaratumab (Anti-PDGFRA / CD140a) | Olaratumab (Anti-PDGFRA / CD140a) supplier | purchase Olaratumab (Anti-PDGFRA / CD140a) | Olaratumab (Anti-PDGFRA / CD140a) cost | Olaratumab (Anti-PDGFRA / CD140a) manufacturer | order Olaratumab (Anti-PDGFRA / CD140a) | Olaratumab (Anti-PDGFRA / CD140a) distributor